Publications
2018-today Malekkou A, Samarani M, Drousiotou A, Votsi C, Sonnino S, Pantzaris M, Chiricozzi E, Zamba-Papanicolaou E, Aureli M, Loberto N, Christodoulou ...
The main research interests of the Neuro-epidemiology Department include:
Participation in Clinical Trials (OLE, Helios, IONIS): Clinical Trials for patients with Familial Amyloid Polyneuropathy (FAP) since 2015.
Rare Neurological Disease: Investigation of phenotype/genotype correlations, clinical phenotypes, familiar clustering and epidemiology of rare disease such as Huntington ’s disease and Amyotrophic Lateral Sclerosis.
The Department is also interested in the genomics, proteomics and metabolomics and epigenomics of both rare diseases (HD and ALS) and more complex diseases such as PD.
The clinical members have become Regular Members of the European Huntington’s Disease Network (EHDN).
Neuromuscular Diseases: Investigation of the phenotype, phenotype/genotype correlations, epidemiology and genomics, SNPs and methyl-omics of neuromuscular diseases such as ALS, Ataxias and FAP.
The Neuroepidemiology Department focuses on designing and conducting studies investigating the distribution and determinants of genetics, molecular and environmental factors of various neurological disease such as Amyotrophic Lateral Sclerosis (ALS), Parkinson’s Disease (PD), Huntington’s Disease (HD), Ataxia’s. Some of the publications of the department include:
2018-today Malekkou A, Samarani M, Drousiotou A, Votsi C, Sonnino S, Pantzaris M, Chiricozzi E, Zamba-Papanicolaou E, Aureli M, Loberto N, Christodoulou ...
Research Grants to the Neuroepidemiology Department: Seed Fund from the European Huntington’s Disease Network-“Untargeted ...